Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Calverley, B. Celli, J. Anderson, G. Ferguson, C. Jenkins, P. Jones, J. Yates, J. Vestbo (Liverpool, Greenford, London, Manchester, United Kingdom; Boston, MA, Livonia, MI, RTP, NC, United States Of America; Sydney, Australia). Factors associated with mortality in the TORCH trial in COPD. Eur Respir J 2007; 30: Suppl. 51, 2144

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002 Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Adherence to medication, mortality and severe exacerbations in the TORCH study Source: Annual Congress 2008 - COPD Year: 2008 Predictor factors of mortality in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006 Risk of non-lower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Incidence and risk factors for acute exacerbations of asthma during pregnancy: A prospective observational study of 500 pregnancies Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease Year: 2013 Factors affecting mortality and morbidity in patients with bronchiectasis Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Predictors of mortality in a well-characterised group of patients with COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Factors associated with exacerbations in US patients with COPD Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study Source: International Congress 2018 – New developments in paediatric asthma Year: 2018 Predictive factors of mortality in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007 Incidence and risk factors of frequent asthma exacerbations in a multinational, multidatabase cohort study Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Key factors associated with readmission in COPD patients Source: Annual Congress 2013 –COPD biomarkers Year: 2013